ORBIMED PRIVATE INVESTMENTS IX, LP
Profile
Company Names
ORBIMED PRIVATE INVESTMENTS IX, LP
Addresses
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY 10022
Phone Numbers
212-739-6400
Entity Type:
LIMITED PARTNERSHIP
Industry:
PRIVATE EQUITY FUND
Year Incorporated:
2022
State Incorporated:
DELAWARE
Total Amount Raised:
$1,849,550,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-04-29
$1,849,550,000.00
$1,900,000,000.00
$50,450,000.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
P.
BONITA
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP
| CLEMENTIA PHARMACEUTICALS INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
SVEN
H.
BORHO
EXECUTIVE OFFICER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED PARTNERS, LTD.
| ORBIMED GLOBAL HEALTHCARE FUND, LTD.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, LTD.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED GENESIS FUND, LTD.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
CARL
L.
GORDON
EXECUTIVE OFFICER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| AMARIN CORP PLC\UK
| SELECTA BIOSCIENCES INC
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| ACCELERON PHARMA INC
| SINGULEX INC
| SINGULEX, INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| COMPASS THERAPEUTICS, INC.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
GEOFFREY
C.
HSU
EXECUTIVE OFFICER
CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
W.
CARTER
NEILD
EXECUTIVE OFFICER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
N/A
ORBIMED ADVISORS LLC
EXECUTIVE OFFICER
MATTHEW
S.
RIZZO
EXECUTIVE OFFICER
C.
SCOTLAND
STEVENS
EXECUTIVE OFFICER
ORBIMED PARTNERS II, L.P.
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
PETER
A.
THOMPSON
EXECUTIVE OFFICER
RESPONSE BIOMEDICAL CORP
| SILVERBACK THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
